Literature DB >> 22803639

Functional disability and health-related quality of life in South Africans with early rheumatoid arthritis.

B Hodkinson1, E Musenge, M Ally, P W A Meyer, R Anderson, M Tikly.   

Abstract

BACKGROUND: The severity and predictors of functional disability and health-related quality of life (HRQoL) in a cohort of South Africans with early rheumatoid arthritis (RA) were investigated.
METHODS: Changes in the Health Assessment Questionnaire Disability Index (HAQ) and the 36-Item Short Form Health Survey (SF-36) following 12 months of traditional disease-modifying anti-rheumatic drugs (DMARDs) were studied in previously DMARD-naïve adults with disease duration ≤ 2 years.
RESULTS: The majority of the 171 patients were female (82%), Black Africans (89%) with a mean (SD) symptom duration of 11.6 (7.0) months. In the 134 patients seen at 12 months, there were significant improvements in the HAQ and all domains of the SF-36 but 92 (69%) still had substantial functional disability (HAQ > 0.5) and 89 (66%) had suboptimal mental health [SF-36 mental composite score (MCS) < 66.6]. Multivariate analysis showed that female sex (p = 0.05) and high baseline HAQ score (p < 0.01) predicted substantial functional disability at 12 months. Unemployment (p = 0.03), high baseline pain (p = 0.02), and HAQ score (p = 0.04) predicted suboptimal mental health, with a trend towards a low level of schooling being significant (p = 0.08).
CONCLUSIONS: Early RA has a broad impact on HRQoL in indigent South Africans, with a large proportion of patients still showing substantial functional disability and suboptimal mental health despite 12 months of DMARD therapy. Further research is needed to establish the role of interventions including psychosocial support, rehabilitation programmes, and biological therapy to improve physical function and HRQoL in this population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22803639     DOI: 10.3109/03009742.2012.676065

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  10 in total

1.  Rheumatoid arthritis in the Middle East and Africa: are we any closer to optimising its management?

Authors:  Jamal Al Saleh; Gaafar Ragab; Peter Nash; Hussein Halabi; Ahmed Laatar; Ali M El-Sayed Yousef; Hamdi Ehsouna; Mohammed Hammoudeh
Journal:  Clin Rheumatol       Date:  2014-11-07       Impact factor: 2.980

2.  Rheumatoid arthritis in the developing world: stepping up to the challenge.

Authors:  Bridget Hodkinson; Mohammed Tikly; Ade Adebajo
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

3.  Mental health status of women with rheumatoid arthritis in iran.

Authors:  Sousan Kolahi; Hamid Noshad; Ali Fakhari; Ali Reza Khabbazi; Mehrzad Hajaliloo; Leila Ghahremani Nasab
Journal:  Iran Red Crescent Med J       Date:  2014-02-02       Impact factor: 0.611

4.  Sleep quality in Chinese patients with rheumatoid arthritis: contributing factors and effects on health-related quality of life.

Authors:  Genkai Guo; Ting Fu; Rulan Yin; Lijuan Zhang; Qiuxiang Zhang; Yunfei Xia; Liren Li; Zhifeng Gu
Journal:  Health Qual Life Outcomes       Date:  2016-11-16       Impact factor: 3.186

5.  Prevalence of depressive symptoms in patients with rheumatoid arthritis at a regional hospital in KwaZulu-Natal, South Africa.

Authors:  Mfundo Mabusela; Andrew Tomita; Saeeda Paruk; Farhanah Paruk
Journal:  S Afr J Psychiatr       Date:  2022-02-22       Impact factor: 1.550

6.  Comorbidities in Black South Africans with established rheumatoid arthritis.

Authors:  Vikash Lala; Mohammed Tikly; Eustasius Musenge; Nimmisha Govind
Journal:  Int J Rheum Dis       Date:  2022-05-03       Impact factor: 2.558

Review 7.  A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective.

Authors:  Peter C Taylor; Adam Moore; Radu Vasilescu; Jose Alvir; Miriam Tarallo
Journal:  Rheumatol Int       Date:  2016-01-08       Impact factor: 2.631

8.  Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: Exploratory Analyses from RA-BEAM.

Authors:  Bruno Fautrel; Bruce Kirkham; Janet E Pope; Tsutomu Takeuchi; Carol Gaich; Amanda Quebe; Baojin Zhu; Inmaculada de la Torre; Francesco De Leonardis; Peter C Taylor
Journal:  J Clin Med       Date:  2019-09-05       Impact factor: 4.241

9.  Tobacco-Derived Lipopolysaccharide, Not Microbial Translocation, as a Potential Contributor to the Pathogenesis of Rheumatoid Arthritis.

Authors:  Pieter W A Meyer; Mahmood M T M Ally; Mohammed Tikly; Gregory Tintinger; Lai Ling Winchow; Helen Steel; Ronald Anderson
Journal:  Mediators Inflamm       Date:  2019-11-03       Impact factor: 4.711

10.  [Profile and quality of life of patients with rheumatoid arthritis in Guinea Conakry and Cameroon].

Authors:  Aly Badra Kamissoko; Paul Eloundou; Marie Traoré; Mamadou Lamine Diallo; Gervais Mendo; M'balou Fatoumata Diallo; Alhassane Diallo
Journal:  Pan Afr Med J       Date:  2021-04-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.